title: Women's health 2015: an update for the internist.
abstract: The field of women's health is varied and dynamic. Major studies in 2014 and the first half of 2015 suggest that selective serotonin reuptake inhibitors are not strongly associated with congenital heart defects, that paroxetine 7.5 mg is effective for treating menopausal symptoms, and that women with heart failure may benefit more from cardiac resynchronization therapy than men.
authors.affiliation: Associate Professor, Department of Medicine, Division of Women's Health Internal Medicine, Mayo Clinic, Scottsdale, AZ, USA. E-mail: kransdorf.lisa@mayo.edu.
authors.forename: Lisa N
authors.initials: LN
authors.lastname: Kransdorf
authors.affiliation: Professor, Department of Medicine, Division of General Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
authors.forename: Melissa A
authors.initials: MA
authors.lastname: McNeil
authors.affiliation: Associate Professor, Department of Medicine, Division of Women's Health Internal Medicine, Mayo Clinic, Scottsdale, AZ, USA.
authors.forename: Julia A
authors.initials: JA
authors.lastname: Files
authors.affiliation: Professor, Laura W. Bush Institute for Women's Health, Texas Tech University Health Sciences Center, Amarillo, TX, USA.
authors.forename: Marjorie R
authors.initials: MR
authors.lastname: Jenkins
mesh_terms: D002983:Clinical Competence; D003863:Depression / Q000188:drug therapy*; D064420:Drug-Related Side Effects and Adverse Reactions / Q000517:prevention & control*; D005260:Female; D006801:Humans; D017374:Paroxetine / Q000494:pharmacology*; D012307:Risk Factors; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology; D016387:Women's Health
chemical_list: D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors